PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

Emulsions as vehicles for the controlled release of astaxanthin in topical application

Treść / Zawartość
Identyfikatory
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
In the work, the antioxidant activity of astaxanthin (AST) and the influence of the base formulation on the kinetics of AST release were studied. Three stable O/W AST-loaded emulsions, differing in droplet size (12.7 m(E1), 3.8 m(E2), 3.2 m(E3)) and a nanoemulsion (0.13 m, NE) were prepared. The results confirmed very strong antioxidant activity of AST. The emulsion internal phase droplet size did not significantly affect the AST release. The amount of released AST was respectively: 13.60% (E1), 11.42% (E2), 9.45% (E3), 9.71% (NE). The best fit to experimental data was obtained using the Higuchi model for emulsions and the Korsmeyer-Peppas model for NE. The results show that the AST release process is limited by the diffusion through carriers and the prepared O/W emulsions can be applied as vehicles for delivery of astaxanthin to the skin, ensuring effective anti-aging action of the cosmetics.
Rocznik
Strony
439--–450
Opis fizyczny
Bibliogr. 37 poz., tab., rys.
Twórcy
  • Cracow University of Technology, Faculty of Chemical Engineering and Technology, Warszawska 24, 31-155 Kraków, Poland
  • Cracow University of Technology, Faculty of Chemical Engineering and Technology, Warszawska 24, 31-155 Kraków, Poland
Bibliografia
  • 1. Aboofazeli R., 2010. Nanometric-scaled emulsions (nanoemulsions). Iran. J. Pharm. Res., 9, 4, 325–326.
  • 2. Al-Bulish M.S.M., Xue C., Waly M.I., Xu J., Wang Y., Tang Q-J., 2017. The defensive role of antioxidants astaxanthin against oxidative damage in diabetic rats injected with streptozotocin. J. Food Nutr. Res., 5, 191–196. DOI: 10.12691/jfnr-5-3-9.
  • 3. Chang C-S., Chang C-L., Lai G-H., 2013. Reactive oxygen species scavenging activities in a chemiluminescence model and neuroprotection in rat pheochromocytoma cells by astaxanthin, beta-carotene and canthaxanthin. Kaohsiung J. Med. Sci., 29, 412–421. DOI: 10.1016/j.kjms.2012.12.002.
  • 4. Chekanov K., Lobakova E., Selyakh I., Semenova L., Sidorov R., Solovchenko A., 2014. Accumulation of astaxanthin by a new Haematococcus pluvialis strain BM1 from the white sea coastal rocks (Russia). Mar Drugs, 12, 4504–4520. DOI: 10.3390/md12084504.
  • 5. Chen Z., Li W., Shi L., Jiang L., Li M., Zhang C., Peng H., 2020. Kidney-targeted astaxanthin natural antioxidant nanosystem for diabetic nephropathy therapy. Eur. J. Pharm. Biopharm., 156, 143–154. DOI: 10.1016/j.ejpb.2020.09.005.
  • 6. Chew W., Mathison B., Kimble L., Mixter P.F., Chew B.P., 2013. Astaxanthin decreases inflammatory biomarkers associated with cardiovascular disease in human umbilical vein endothelial cells. Am. J. Food Technol., 1, 1–17 DOI: 10.7726/ajafst.2013.1001.
  • 7. Costa P., Lobo J.M.S., 2001. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci., 13, 123–133. DOI: 10.1016/s0928-0987(01)00095-1.
  • 8. Dash S., Murthy P.N., Nath L., Chowdhury P., 2010. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol. Pharm., 67, 3, 217–223.
  • 9. El-Mahrab-Robert M., Rosilio V., Bolzinger M.A., Chaminade P., Grossiord J.L., 2008. Assessment of oil polarity: Comparison of evaluation methods. Int. J. Pharm., 348, 89–94. DOI: 10.1016/j.ijpharm.2007.07.027.
  • 10. Fang Q., Guo S., Zhou H., Han R.,Wu P., Han C., 2017. Astaxanthin protects against early burn-wound progression in rats by attenuating oxidative stress-induced inflammation and mitochondria-related apoptosis. Sci. Rep., 7, 41440. DOI: 10.1038/srep41440.
  • 11. Guerin M., Huntley M.E., Olaizola M., 2003. Haematococcus astaxanthin: applications for human health and nutrition. Trends Biotechnol., 21, 210–216. DOI: 10.1016/S0167-7799(03)00078-7.
  • 12. ] Higuchi T., 1961. Rate of release of medicaments from ointment bases containing drugs in suspension. J. Pharm. Sci., 50, 874–875. DOI: 10.1002/jps.2600501018.
  • 13. Higuchi T., 1963. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci., 52, 1145–1149. DOI: 10.1002/jps.2600521210.
  • 14. ] Higuera-Ciapara I., Felix-Valenzuela L., Goycoolea F.M., 2006. Astaxanthin: A review of its chemistry and applications. Crit. Rev. Food Sci. Nutr., 46, 185–196. DOI: 10.1080/10408690590957188.
  • 15. Izquierdo P., Wiechers J.W., Escribano E., Garcia-Celma M.J., Tadros T.F., Esquena J., Dederen J.C., Solans C., 2007. A study on the influence of emulsion droplet size on the skin penetration of tetracaine. Skin Pharmacol. Physiol., 20, 263–270. DOI: 10.1159/000106076.
  • 16. Jaworska M., Sikora E., Zielina M., Ogonowski J., 2013. Studies on the formation of O/W nano-emulsions, by low-energy emulsification method, suitable for cosmeceutical applications. Acta Biochim. Pol., 60, 779–782. DOI: 10.18388/abp.2013_2057.
  • 17. Komatsu T., Sasaki S., Manabe Y., Hirata T., Sugawara T., 2017. Preventive effect of dietary astaxanthin on UVA-induced skin photoaging in hairless mice. PLoS ONE, 12, e0171178. DOI: 10.1371/journal.pone.0171178.
  • 18. Lason E., 2020. Sub-micron vehicles of biologically active substances, In: Sikora E., Miastkowska M., Lason E. (Eds.), Selected skin delivery systems. Wydawnictwo PK, Krakow, 80–109.
  • 19. Lee H.S., Sung D.K., Kim S.H., Choi W.I., Hwang E.T., Choi D.J., Chang J.H., 2017. Controlled release of astaxanthin from nanoporous silicified-phospholipids assembled boron nitride complex for cosmetic applications. Appl. Surf. Sci., 424, 15–19. DOI: 10.1016/j.apsusc.2017.03.036.
  • 20. Lorenz R.T., Cysewski G.R., 2000. Commercial potential for Haematococcus microalgae as a natural source of astaxanthin. Trends Biotechnol., 18, 160–167. DOI: 10.1016/s0167-7799(00)01433-5.
  • 21. Meephansan J., Rungjang A., YingmemaW., Deenonpoe R., Ponnikorn S., 2017. Effect of astaxanthin on cutaneous wound healing. Clin. Cosmet. Invest. Dermatol., 10, 259–265. DOI: 10.2147/CCID.S142795.
  • 22. Okonogi S., Riangjanapatee P., 2015. Physicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administration. Int. J. Pharm., 478, 726–735. DOI: 10.1016/j.ijpharm.2014.12.002.
  • 23. Olejnik A., Kapuscinska A., Schroeder G., Nowak I., 2017. Physico-chemical characterization of formulations containing endomorphin-2 derivatives. Amino Acids, 49, 1719–1731. DOI: 10.1007/s00726-017-2470-x.
  • 24. Peppas N.A., Sahlin J.J., 1989. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int. J. Pharm., 57, 169–172. DOI: 10.1016/0378-5173(89)90306-2.
  • 25. Petropoulos J.H., Papadokostaki K.G., Sanopoulou M., 2012. Higuchi’s equation and beyond: Overview of the formulation and application of a generalized model of drug release from polymeric matrices. Int. J. Pharm., 437, 178–191. DOI: 10.1016/j.ijpharm.2012.08.012.
  • 26. Radzali S.A., Baharin B.S., Othman R., Markom M., Rahman R.A., 2014. Co-solvent selection for supercritical fluid extraction of astaxanthin and other carotenoids from Penaeus monodon waste. J. Oleo Sci., 63, 769–777. DOI: 10.5650/jos.ess13184.
  • 27. Re R., Pellegrini N., Proteggente A., Pannala A., Yang M., Rice-Evans C., 1999. Antioxidant activity applying an improvedABTSradical cation decolorization assay. Free Radical Biol. Med., 26, 1231–1237. DOI: 10.1016/s0891-5849(98)00315-3.
  • 28. Regnier P., Bastias J., Rodriguez-Ruiz V., Caballero-Casero N., Caballo C., Sicilia D., Fuentes A., Maire M., Crepin M., Letourneur D., Gueguen V., Rubio S., Pavon-Djavid G., 2015. Astaxanthin from Haematococcus pluvialis prevents oxidative stress on human endothelial cells without toxicity. Mar. Drugs, 13, 2857–2874. DOI: 10.3390/md13052857.
  • 29. Reyes F.A., Mendiola J.A., Ibanez E., del Valle J.M., 2014. Astaxanthin extraction from Haematococcus pluvialis using CO2-expanded ethanol. J. Supercrit. Fluids, 92, 75–83. DOI: 10.1016/j.supflu.2014.05.013.
  • 30. Ritger P.L., Peppas N., 1987. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or disco. J. Controled Release, 5, 23–36. DOI: 10.1016/0168-3659(87)90034-4.
  • 31. Shanmugapriya K., Kim H., Saravana P.S., Chun B.S., Kang H.W., 2018. Astaxanthin-alpha tocopherol nanoemulsion formulation by emulsification methods: Investigation on anticancer, wound healing, and antibacterial effects. Colloids Surf., B, 172, 170–179. DOI: 10.1016/j.colsurfb.2018.08.042.
  • 32. Sikora E., 2019. Cosmetic emulsions. Wydawnictwo PK, Krakow, 35–36.
  • 33. Sikora E., Llinas M., Garcia-Celma M.J., Escribano E., Solans C., 2015. Transdermal delivery of forskolin from emulsions differing in droplet size. Colloids Surf., B, 126, 541–545. DOI: 10.1016/j.colsurfb.2015.01.008.
  • 34. Sila A., Ayed-Ajmi Y., Sayari N., Nasri M., Martinez-Alvarez O., Bougatef A., 2013. Antioxidant and antiproliferative activities of astaxanthin extracted from the shell waste of deep-water pink shrimp (Parapenaeus longirostris). Nat. Prod. J., 3, 82–89. DOI: 10.2174/2210315511303020002.
  • 35. Tirado D.F., Palazzo I., Scognamiglio M., Calvo L., Porta G.D., Reverchon E., 2019. Astaxanthin encapsulation in ethyl cellulose carriers by continuous supercritical emulsions extraction: A study on particle size, encapsulation efficiency, release profile and antioxidant activity. J. Supercrit. Fluids, 150, 128–136. DOI: 10.1016/j.supflu.2019.04.017.
  • 36. Tominaga K., Hongo N., Karato M., Yamashita E., 2012. Cosmetic benefits of astaxanthin on humans subjects. Acta Biochim. Pol., 59, 43–47. DOI: 10.18388/abp.2012_2168.
  • 37. Yuan C., Du L., Jin Z., Xu X., 2013. Storage stability and antioxidant activity of complex of astaxanthin with hydroxypropyl-𝛽-cyclodextrin. Carbohydr. Polym., 91, 385–389. DOI: 10.1016/j.carbpol.2012.08.059.
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-abeb8b89-500c-472f-908c-014f6fbe8773
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.